MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors - Kilian, Michael; Sheinin, Ron; Tan, Chin Leng; Friedrich, Mirco; Krämer, Christopher; Kaminitz, Ayelet; Sanghvi, Khwab; Lindner, Katharina; Chih, Yu-Chan; Cichon, Frederik; Richter, Benjamin; Jung, Stefanie; et al. (Cancer cell, 2023)
Online verfügbar 12 January 2023, Version des Artikels 13 February 2023